A small cohort study in breast cancer examining serum IGFBP-3 levels before and 1 week after palliative chemotherapy demonstrated that patients who showed decreased IGFBP-3 levels after treatment showed poorer OS (170). Here, IGFBP3 is linked to breast cancer.